Stanford researchers in the Swartz lab have proposed a method to synthesize metabolic cofactors from inexpensive substrates for protein synthesis and commodity production applications.
Dr. Maheen Mausoof Adamson and colleagues have developed a personalized non-verbal communication device and associated app for post-stroke expressive aphasia patients.
Using advances in flexible electronics, researchers at Stanford have developed a stretchable strain sensor for monitoring solid tumor size progression on or near the skin in real time.
IPEX syndrome is a severe autoimmune disease with limited treatment options caused by mutations in the forkhead box protein 3 (FOXP3) gene, which plays a critical role in immune regulation.
Stanford inventors have developed a near infrared (NIR) tumor imaging platform that couples a novel rare earth cancer targeting agent and a handheld NIR-IIb fluorescence imager to enable tumor resection down to the few-cell level.
Researchers at Stanford have developed gene editing methods for modifying hematopoietic stem and progenitor cells (HSPCs) to express truncated forms of the erythropoietin receptor (tEPOR).
Polycythemia vera is a rare blood cancer characterized by the hyperproliferation of red blood cells, leading to coagulation events like strokes and heart attacks.
Researchers in the Collaborative Haptics and Robotics in Medicine Lab at Stanford University have developed a monolithically 3D printed haptic device that provides skin pressure, linear and rotational shear, and vibration feedback.
Ultrasound technology is a safe, high-resolution, and cost-efficient tool for imaging. Other modalities, such as MRI or CT, may require the use of anesthesia. This makes it difficult to image pediatric patients and patients sensitive to anesthesia.
Researchers at Stanford have established the safety and penetrance of the dopaminergic prodrug etilevodopa to prevent the progression of myopia ("nearsightedness"). In the past 50 years, myopia prevalence in the U.S.